7857214

Source:http://linkedlifedata.com/resource/pubmed/id/7857214

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016018, umls-concept:C0175906, umls-concept:C0238815, umls-concept:C0392747
pubmed:issue	1
pubmed:dateCreated	1995-3-16
pubmed:language	por
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0421031
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0066-782X
pubmed:author	pubmed-author:PiegasL SLS, pubmed-author:SousaA GAG, pubmed-author:SousaJ EJE
pubmed:issnType	Print
pubmed:volume	63
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	55-6
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:7857214-Brazil, pubmed-meshheading:7857214-Costs and Cost Analysis, pubmed-meshheading:7857214-Fibrinolytic Agents, pubmed-meshheading:7857214-Humans, pubmed-meshheading:7857214-Myocardial Infarction, pubmed-meshheading:7857214-Thrombolytic Therapy
pubmed:year	1994
pubmed:articleTitle	[The dilemma of the Brazilian cardiologist: should the thrombolytic agent be changed?].
pubmed:affiliation	Instituto Dante Pazzanese de Cardiologia - São Paulo.
pubmed:publicationType	Journal Article